Is Home Federal Bancorp, Inc. of Louisiana overvalued or undervalued?
As of November 7, 2025, Home Federal Bancorp, Inc. of Louisiana is rated very attractive due to its undervalued financial ratios, including a P/E of 13 and a Price to Book Value of 0.80, indicating it is trading at a discount compared to peers like HMN Financial, Inc. with a P/E of 21.55, making it a compelling investment opportunity.
As of 7 November 2025, the valuation grade for Home Federal Bancorp, Inc. of Louisiana has moved from attractive to very attractive. The company is currently undervalued based on its key financial ratios, including a P/E ratio of 13, a Price to Book Value of 0.80, and an EV to EBITDA of 4.05. In comparison to peers, HMN Financial, Inc. has a significantly higher P/E ratio of 21.55, indicating that Home Federal Bancorp is trading at a discount relative to some competitors.The company's return metrics are not available for a direct comparison with the S&P 500; however, the overall valuation suggests that it is positioned favorably in the market. Given the attractive valuation ratios and the favorable grade change, Home Federal Bancorp presents a compelling investment opportunity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
